@inproceedings{inproceedings, title  = {{Safety and tolerability of apomorphine sublingual film and subcutaneous apomorphine for the treatment of OFF episodes in Parkinson's disease}},

 url = {{}},

 year = {{2022}},

 month = {{9}},

 author = {{Rascol O and Poewe W and Stocchi F and Chaudhuri R and Kassube J and Manzanares LL and Leta V and Zhang I and Bowling A and Wu S and Pappert E}},

 volume = {{37}},

 journal = {{MOVEMENT DISORDERS}},

 pages = {{S348-S348}},

 note = {{Accessed on 2025/12/11}}}